Medication Information

Psychiatric medications are used to help treat mental health conditions by affecting chemicals in the brain called neurotransmitters, such as serotonin, dopamine, norepinephrine, and gamma-aminobutyric acid (GABA). These medications can help manage symptoms and improve daily functioning when combined with therapy and other treatments.

Mental health professionals prescribe different medications depending on the condition being treated and the individual patient’s needs.

Important Considerations

Psychiatric medications affect individuals differently. Factors such as medical history, other medications, and specific symptoms can influence which treatment is most effective.

Patients should always work with a qualified healthcare provider when starting, stopping, or changing psychiatric medications.

Tips for Finding Reliable Medication Information

Patients should seek medication information from trusted healthcare professionals, such as psychiatrists, primary care providers, and pharmacists. These professionals can provide accurate guidance about how medications work, possible side effects, and safe use.

Reliable information can also be found on reputable medical websites, including National Institute of Mental Health, Mayo Clinic, and American Psychiatric Association. These sources provide evidence-based information reviewed by medical experts.

Patients should be cautious about medication advice from social media, online forums, or influencers without medical training, as this information may not be accurate or safe. Always consult a qualified healthcare provider before making any changes to medications.

General Tips for All Psychiatric Medications

  • Take your medication as prescribed. Do not change your dose or stop taking it without talking to your provider first.

  • Be patient. Many psychiatric medications take weeks to reach their full effect. Give them time to work before deciding they are not helping.

  • Report side effects. Most side effects are manageable, and your provider may be able to adjust your dose or switch medications.

  • Avoid alcohol unless your provider says it is safe. Alcohol can worsen side effects and interfere with treatment.

  • Keep all follow-up appointments. Some medications require regular blood tests or monitoring.

Medical Disclaimer

This information is provided for educational purposes only and should not replace professional medical advice, diagnosis, or treatment. Always consult a licensed healthcare provider for guidance regarding mental health conditions or medications.

References

  1. Simon GE, Moise N, Mohr DC. Management of Depression in Adults: A Review. JAMA. 2024;332(2):141-152. doi:10.1001/jama.2024.5756

  2. Park LT, Zarate CA. Depression in the Primary Care Setting. N Engl J Med. 2019;380(6):559-568. doi:10.1056/NEJMcp1712493

  3. Kalfas M, Tsapekos D, Butler M, et al. Incidence and Nature of Antidepressant Discontinuation Symptoms. JAMA Psychiatry. 2025;82(9):896-904. doi:10.1001/jamapsychiatry.2025.1362

  4. Pillinger T, Howes OD, Correll CU, et al. Antidepressant and Antipsychotic Side-Effects and Personalised Prescribing. Lancet Psychiatry. 2023;10(11):860-876. doi:10.1016/S2215-0366(23)00262-6

  5. Szuhany KL, Simon NM. Anxiety Disorders: A Review. JAMA. 2022;328(24):2431-2445. doi:10.1001/jama.2022.22744

  6. Stein MB, Sareen J. Generalized Anxiety Disorder. N Engl J Med. 2015;373(21):2059-2068. doi:10.1056/NEJMcp1502514

  7. Craske MG, Stein MB. Anxiety. Lancet. 2016;388(10063):3048-3059. doi:10.1016/S0140-6736(16)30381-6

  8. Penninx BW, Pine DS, Holmes EA, Reif A. Anxiety Disorders. Lancet. 2021;397(10277):914-927. doi:10.1016/S0140-6736(21)00359-7

  9. Slee A, Nazareth I, Bondaronek P, et al. Pharmacological Treatments for Generalised Anxiety Disorder: A Systematic Review and Network Meta-Analysis. Lancet. 2019;393(10173):768-777. doi:10.1016/S0140-6736(18)31793-8

  10. Leichsenring F, Leweke F. Social Anxiety Disorder. N Engl J Med. 2017;376(23):2255-2264. doi:10.1056/NEJMcp1614701

  11. U.S. Food and Drug Administration. Buspirone Hydrochloride Prescribing Information. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b9aa144c-cb36-4069-9eaa-7c150298cdd7

  12. Guaiana G, Barbui C, Cipriani A. Hydroxyzine for Generalised Anxiety Disorder. Cochrane Database Syst Rev. 2010;(12):CD006815. doi:10.1002/14651858.CD006815.pub2

  13. Cardoner N, Gutiérrez-Rojas L, Saiz P, et al. Does Pregabalin Offer Potential as a First-Line Therapy for Generalized Anxiety Disorder? Front Pharmacol. 2025;16:1483770. doi:10.3389/fphar.2025.1483770

  14. Hong JSW, Atkinson LZ, Al-Juffali N, et al. Gabapentin and Pregabalin in Bipolar Disorder, Anxiety States, and Insomnia. Mol Psychiatry. 2022;27(3):1339-1349. doi:10.1038/s41380-021-01386-6

  15. Archer C, Wiles N, Kessler D, et al. Beta-Blockers for the Treatment of Anxiety Disorders. J Affect Disord. 2025;368:90-99. doi:10.1016/j.jad.2024.09.068

  16. Carvalho AF, Firth J, Vieta E. Bipolar Disorder. N Engl J Med. 2020;383(1):58-66. doi:10.1056/NEJMra1906193

  17. Nierenberg AA, Agustini B, Köhler-Forsberg O, et al. Diagnosis and Treatment of Bipolar Disorder: A Review. JAMA. 2023;330(14):1370-1380. doi:10.1001/jama.2023.18588

  18. McIntyre RS, Berk M, Brietzke E, et al. Bipolar Disorders. Lancet. 2020;396(10265):1841-1856. doi:10.1016/S0140-6736(20)31544-0

  19. Cortese S. Pharmacologic Treatment of Attention Deficit-Hyperactivity Disorder. N Engl J Med. 2020;383(11):1050-1056. doi:10.1056/NEJMra1917069

  20. Posner J, Polanczyk GV, Sonuga-Barke E. Attention-Deficit Hyperactivity Disorder. Lancet. 2020;395(10222):450-462. doi:10.1016/S0140-6736(19)33004-1

  21. Morin CM, Buysse DJ. Management of Insomnia. N Engl J Med. 2024;391(3):247-258. doi:10.1056/NEJMcp2305655